Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ariel Isser

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
The Journal of Clinical Investigation|December 12, 2018
High-affinity T cell receptors for adoptive cell transferAriel Isser, Jonathan P Schneck
Biomaterials|December 18, 2020
Biomaterials to enhance antigen-specific T cell expansion for cancer immunotherapyAriel Isser, Natalie K Livingston, Jonathan P Schneck
ACS Biomaterials Science & Engineering|January 9, 2021
Collagen Fiber Architecture Regulates Hypoxic Sarcoma Cell MigrationDaniel M Lewis, Vitor Tang, Nupur Jain, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2020
Rapid Expansion of Highly Functional Antigen-Specific T Cells from Patients with Melanoma by Nanoscale Artificial Antigen-Presenting CellsJunya Ichikawa, Tatsuya Yoshida, Ariel Isser, et al.
Nano Letters|June 30, 2020
Adaptive Nanoparticle Platforms for High Throughput Expansion and Detection of Antigen-Specific T cellsJohn W Hickey, Ariel Isser, Sebastian F Salathe, et al.
ACS Nano|June 20, 2025
Specific Stimulation and Multiplex Secretion Analysis of T Cells Using a Suspendable Hydrogel Platform Enables Immunophenotyping at the Single-Cell ScaleMonika Kizerwetter, Doyeon Koo, Citradewi Soemardy, et al.
ACS Applied Materials & Interfaces|February 12, 2021
Biodegradable Cationic Polymer Blends for Fabrication of Enhanced Artificial Antigen Presenting Cells to Treat MelanomaKelly R Rhodes, Ariel Isser, John W Hickey, et al.
Acta Biomaterialia|February 22, 2023
Shape matters: Biodegradable anisotropic nanoparticle artificial antigen presenting cells for cancer immunotherapyElana Ben-Akiva, John W Hickey, Randall A Meyer, et al.
JCI Insight|April 24, 2020
Commensal bacteria stimulate antitumor responses via T cell cross-reactivityCatherine A Bessell, Ariel Isser, Jonathan J Havel, et al.
JCI Insight|September 22, 2022
Cross-reactivity of SARS-CoV-2- and influenza A-specific T cells in individuals exposed to SARS-CoV-2Worarat Chaisawangwong, Hanzhi Wang, Theodore Kouo, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
The Journal of Clinical Investigation|December 12, 2018
High-affinity T cell receptors for adoptive cell transferAriel Isser, Jonathan P Schneck
Biomaterials|December 18, 2020
Biomaterials to enhance antigen-specific T cell expansion for cancer immunotherapyAriel Isser, Natalie K Livingston, Jonathan P Schneck
ACS Biomaterials Science & Engineering|January 9, 2021
Collagen Fiber Architecture Regulates Hypoxic Sarcoma Cell MigrationDaniel M Lewis, Vitor Tang, Nupur Jain, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2020
Rapid Expansion of Highly Functional Antigen-Specific T Cells from Patients with Melanoma by Nanoscale Artificial Antigen-Presenting CellsJunya Ichikawa, Tatsuya Yoshida, Ariel Isser, et al.
Nano Letters|June 30, 2020
Adaptive Nanoparticle Platforms for High Throughput Expansion and Detection of Antigen-Specific T cellsJohn W Hickey, Ariel Isser, Sebastian F Salathe, et al.
ACS Nano|June 20, 2025
Specific Stimulation and Multiplex Secretion Analysis of T Cells Using a Suspendable Hydrogel Platform Enables Immunophenotyping at the Single-Cell ScaleMonika Kizerwetter, Doyeon Koo, Citradewi Soemardy, et al.
ACS Applied Materials & Interfaces|February 12, 2021
Biodegradable Cationic Polymer Blends for Fabrication of Enhanced Artificial Antigen Presenting Cells to Treat MelanomaKelly R Rhodes, Ariel Isser, John W Hickey, et al.
Acta Biomaterialia|February 22, 2023
Shape matters: Biodegradable anisotropic nanoparticle artificial antigen presenting cells for cancer immunotherapyElana Ben-Akiva, John W Hickey, Randall A Meyer, et al.
JCI Insight|April 24, 2020
Commensal bacteria stimulate antitumor responses via T cell cross-reactivityCatherine A Bessell, Ariel Isser, Jonathan J Havel, et al.
JCI Insight|September 22, 2022
Cross-reactivity of SARS-CoV-2- and influenza A-specific T cells in individuals exposed to SARS-CoV-2Worarat Chaisawangwong, Hanzhi Wang, Theodore Kouo, et al.
Pageof 2